News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
292,503 Results
Type
Article (15534)
Company Profile (229)
Press Release (276733)
Multimedia
Podcasts (114)
Webinars (13)
Section
Business (90686)
Career Advice (168)
Deals (13476)
Drug Delivery (55)
Drug Development (50981)
Employer Resources (32)
FDA (5974)
Job Trends (5208)
News (145720)
Policy (10089)
Tag
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (6)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (963)
Accelerated approval (35)
ADA (33)
Adcomms (16)
Allergies (119)
Alliances (21766)
ALS (182)
Alzheimer's disease (1212)
Antibody-drug conjugate (ADC) (481)
Approvals (6339)
Artificial intelligence (420)
ASCO (221)
Autoimmune disease (321)
Automation (17)
Bankruptcy (110)
Best Places to Work (4558)
BIO (54)
Biologics (11)
BIOSECURE Act (6)
Biosimilars (143)
BioSpace Insights (74)
Biotechnology (177)
Bispecific (1)
Bladder cancer (129)
Brain cancer (64)
Breast cancer (463)
Cancer (4458)
Cardiovascular disease (333)
Career advice (163)
Career pathing (13)
CAR-T (307)
CDC (8)
CDMO (96)
Celiac Disease (1)
Cell therapy (802)
Cervical cancer (26)
Clinical research (45735)
Collaboration (1617)
Commercialization (5)
Company closure (4)
Compensation (893)
Complete response letters (68)
COVID-19 (1138)
CRISPR (118)
C-suite (934)
Cystic fibrosis (127)
Data (6501)
Denatured (24)
Depression (127)
Dermatology (83)
Diabetes (365)
Diagnostics (1514)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (324)
Drug pricing (54)
Drug shortages (3)
Duchenne muscular dystrophy (317)
Earnings (33361)
Editorial (36)
Employer branding (4)
Employer resources (30)
Events (54361)
Executive appointments (761)
FDA (8508)
Fibrodysplasia Ossificans Progressiva (8)
Fragile X (1)
Friedreich's ataxia (24)
Frontotemporal dementia (33)
Funding (1362)
Gene editing (244)
Generative AI (42)
Gene therapy (661)
GLP-1 (596)
Government (1200)
Grass and pollen (3)
Guidances (179)
Healthcare (6777)
Hematology (118)
HIV (32)
Huntington's disease (62)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (105)
Immunology and inflammation (266)
Immuno-oncology (98)
Indications (156)
Infectious disease (1307)
Inflammatory bowel disease (189)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (239)
Interviews (20)
IPO (7404)
IRA (13)
Job creations (871)
Job search strategy (135)
JPM (41)
Kidney cancer (12)
Labor market (38)
Layoffs (270)
Leadership (16)
Legal (1403)
Licensing (20)
Liver cancer (50)
Longevity (29)
Lung cancer (599)
Lymphoma (340)
Machine learning (36)
Management (8)
Manufacturing (625)
Marketing (9)
MASH (174)
Medical affairs (2)
Medical device (2744)
Medtech (2785)
Mergers & acquisitions (6901)
Metabolic disorders (1007)
mRNA (191)
Multiple sclerosis (136)
Multispecific (1)
NASH (14)
Neurodegenerative disease (385)
Neuropsychiatric disorders (96)
Neuroscience (2558)
Neurotech (1)
NextGen: Class of 2026 (2040)
Non-profit (886)
Now hiring (43)
Obesity (445)
Opinion (152)
Ovarian cancer (201)
Pain (153)
Pancreatic cancer (267)
Parkinson's disease (337)
Partnered (15)
Patents (459)
Patient advocacy (1)
Patient recruitment (655)
Peanut (51)
People (27634)
Peptides (4)
Pharmaceutical (29)
Pharmacy benefit managers (7)
Phase 1 (16199)
Phase 2 (21249)
Phase 3 (13447)
Pipeline (7526)
Policy (109)
Postmarket research (853)
Preclinical (6833)
Press Release (30)
Prostate cancer (219)
Psychedelics (75)
Radiopharmaceuticals (313)
Rare diseases (1025)
Real estate (1459)
Recruiting (12)
Regulatory (11072)
Reports (27)
Research institute (1000)
Resumes & cover letters (20)
Rett syndrome (44)
RNA editing (32)
RSV (25)
Schizophrenia (161)
Series A (265)
Series B (185)
Service/supplier (1)
Sickle cell disease (100)
Special edition (21)
Spinal muscular atrophy (128)
Sponsored (19)
Startups (2044)
State (1)
Stomach cancer (5)
Supply chain (42)
Tariffs (19)
The Weekly (88)
Vaccines (441)
Venture capital (103)
Weight loss (238)
Women's health (52)
Worklife (3)
Date
Last 7 days (378)
Last 30 days (1338)
Last 365 days (18089)
2026 (12697)
2025 (18093)
2024 (20464)
2023 (22412)
2022 (26810)
2021 (27803)
2020 (23356)
2019 (16223)
2018 (11735)
2017 (13743)
2016 (11838)
2015 (14348)
2014 (10392)
2013 (7483)
2012 (7532)
2011 (7614)
2010 (7430)
Location
Africa (156)
Alabama (81)
Alaska (2)
Arizona (96)
Arkansas (6)
Asia (19018)
Australia (3266)
California (9519)
Canada (2392)
China (1211)
Colorado (339)
Connecticut (357)
Delaware (328)
Europe (40768)
Florida (1248)
Georgia (272)
Hawaii (3)
Idaho (18)
Illinois (588)
India (62)
Indiana (227)
Iowa (10)
Japan (357)
Kansas (89)
Kentucky (12)
Louisiana (18)
Maine (14)
Maryland (978)
Massachusetts (7591)
Michigan (136)
Minnesota (332)
Mississippi (3)
Missouri (38)
Montana (17)
Nebraska (6)
Nevada (55)
New Hampshire (22)
New Jersey (2146)
New Mexico (14)
New York (2339)
North Carolina (1112)
North Dakota (7)
Northern California (4885)
Ohio (233)
Oklahoma (11)
Oregon (26)
Pennsylvania (1729)
Puerto Rico (12)
Rhode Island (27)
South America (217)
South Carolina (15)
Southern California (3853)
Tennessee (67)
Texas (1325)
United States (31409)
Utah (131)
Virginia (195)
Washington D.C. (37)
Washington State (777)
West Virginia (1)
Wisconsin (71)
292,503 Results for "medeor therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Medeor Therapeutics Announces Interim Data from Pivotal Trial Showing Cell Therapy Technology Could Eliminate Life-Long Need for Immunosuppressant Drugs Following Kidney Transplant
Medeor Therapeutics announced positive interim data from its multicenter, international Phase III clinical trial.
November 2, 2023
·
5 min read
Biotech Bay
Medeor Therapeutics to Present Interim Pivotal Data on MDR-101 Cell Therapy for Induction of Immune Tolerance and Elimination of Immunosuppressants Following Kidney Transplant in Late Breaker Oral Presentation at ASN Kidney Week 2023
Medeor Therapeutics announced that it will present interim Phase 3 data investigating if MDR-101 cell therapy can safely induce immune tolerance and eliminate the need for immunosuppressive drugs vs. standard of care following a kidney transplant as a late-breaking oral presentation at the American Society of Nephrology Kidney Week, November 1-5, 2023 in Philadelphia, Pennsylvania.
October 25, 2023
·
1 min read
Press Releases
ME Therapeutics Advances In Vivo CAR and Therapeutic mRNA STING Programs
September 8, 2026
·
6 min read
Press Releases
Mighty Therapeutics Initiates IND-Enabling Studies of MYTX-255: a Mitochondrial-Targeted Therapeutic Candidate
September 9, 2026
·
3 min read
Press Releases
Exonate Becomes Foventa Therapeutics
September 1, 2026
·
2 min read
Press Releases
TransCode Therapeutics Announces Leadership Transition
September 10, 2026
·
4 min read
Press Releases
Silence Therapeutics to Participate in Three September 2026 Investor Conferences
September 2, 2026
·
1 min read
Press Releases
Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio
August 19, 2026
·
12 min read
Press Releases
United Therapeutics Corporation Acquires Thymmune Therapeutics
July 2, 2026
·
4 min read
Press Releases
Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer
September 9, 2026
·
2 min read
1 of 29,251
Next
